These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 395071)
1. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system. Mirouze J; Selam JL; Pham TC; Orsetti A Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071 [TBL] [Abstract][Full Text] [Related]
2. [Remission of diabetes during conventional insulin therapy or therapy controlled by use of an artificial pancreas]. Mirouze J; Selam JL; Pham TC; Mendoza E Sem Hop; 1979 Feb 18-25; 55(7-8):354-9. PubMed ID: 220725 [TBL] [Abstract][Full Text] [Related]
3. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics. Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097 [TBL] [Abstract][Full Text] [Related]
4. Continuous intravenous insulin therapy with a miniaturized open-loop system. Renner R; Hepp KD; Mehnert H; Franetzki M Horm Metab Res Suppl; 1979; (8):186-90. PubMed ID: 395077 [TBL] [Abstract][Full Text] [Related]
5. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator). Christiansen JS; Svendsen PA; Deckert T Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069 [TBL] [Abstract][Full Text] [Related]
6. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas. Lambert AE; Buysschaert M; Lambotte L Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067 [No Abstract] [Full Text] [Related]
7. Comparison of a perfusion syringe (Mill Hill Infusor) and a glucose-controlled insulin infusion system in the regulation of diabetes mellitus. Stavljenić A; Granić M; Topić B; Skrabalo Z Horm Metab Res Suppl; 1979; (8):207-11. PubMed ID: 395083 [TBL] [Abstract][Full Text] [Related]
8. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen. Irsigler K; Kritz H; Kaspar L; Brändle J; Franetzki M Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070 [TBL] [Abstract][Full Text] [Related]
9. Closed-loop system in evaluation of insulin infusion rates for an open-loop system. Kølendorf K; Christiansen JS; Svendsen PA; Bojsen J Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082 [TBL] [Abstract][Full Text] [Related]
10. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months. Beyer J; Wolf E; Cordes U; Hassingen W Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068 [TBL] [Abstract][Full Text] [Related]
11. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics. Kerner W; Beischer W; Maier V; Pfeiffer EF Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094 [TBL] [Abstract][Full Text] [Related]
12. Development of a closed-loop artificial pancreas. Kraegen EW; Whiteside R; Bell D; Chia YO; Lazarus L Horm Metab Res Suppl; 1979; (8):38-42. PubMed ID: 395087 [TBL] [Abstract][Full Text] [Related]
13. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics. Neuhaus C; Kerner W; Maier V; Pfeiffer EF Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066 [TBL] [Abstract][Full Text] [Related]
14. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell. Altomare E; Moulin JP; Tavares S; Bourelly N; Lassmann V; Vague P Horm Metab Res Suppl; 1979; (8):110-5. PubMed ID: 395065 [No Abstract] [Full Text] [Related]
15. Variation induced by a three-days application of the artificial beta-cell on glucagon, growth hormone and catecholamine secretion, glycosylated hemoglobin, and erythrocyte 2,3-diphosphoglycerate concentration. Brunetti P; Massi-Benedetti M; Puxeddu A; Santeusanio F; Calabrese G; Bolli G; Scionti L; Angeletti G Horm Metab Res Suppl; 1979; (8):81-6. PubMed ID: 395095 [TBL] [Abstract][Full Text] [Related]
16. Optimal blood sugar control in labile diabetics using a portable open-loop insulin infusion system with a flexible program. Froesch ER; Blatter G; Morell B Horm Metab Res Suppl; 1979; (8):198-201. PubMed ID: 395079 [TBL] [Abstract][Full Text] [Related]
17. [Juvenile diabetes of recent onset. Sustained insulin remission by means of preprogrammed insulin infusion (author's transl)]. Pinget M; Blickle JF; Anceau A; Audhuy B; Jacques C; Brogard JM; Dorner M Nouv Presse Med; 1981 Apr; 10(17):1381-4. PubMed ID: 7015270 [TBL] [Abstract][Full Text] [Related]
18. Clinical application of pre-programmed insulin infusion: continuous subcutaneous insulin therapy with a portable infusion system. Pickup JC; Viberti GC; Keen H; Parsons JA; Alberti KG Horm Metab Res Suppl; 1979; (8):202-4. PubMed ID: 395081 [TBL] [Abstract][Full Text] [Related]
19. Preprogrammed insulin infusion with a portable pump system. Irsigler K; Kritz H; Kaspar L; Brändle J; Koller W; Franetzki M Horm Metab Res Suppl; 1979; (8):193-7. PubMed ID: 119699 [TBL] [Abstract][Full Text] [Related]
20. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]